ARCHIVES

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Group Chairs Urge Implementation of NCI plan. Next Step: Bioinformatics and Tissue Banks

November 11, 2011

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984

NCI Advisory Group, Other Cancer Meetings

August 19, 1983

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency

August 14, 1992

Hiring Freeze Squeezes NIH, NCI

August 3, 1979